The National Academy of Inventors (NAI) has named 54 academic inventors to the Spring 2019 class of NAI SeniorMembers, including Stan Gerson, MD, Director of the Case Comprehensive Cancer Center (Case CCC).
NAI Senior Members are active faculty, scientists and administrators from its Member Institutions who have demonstrated remarkable innovation producing technologies that have brought, or aspire to bring, real impact on the welfare of society. They also have proven success in patents, licensing and commercialization.
Gerson, who is also Director of the National Center for Regenerative Medicine at Case Western Reserve University, holds 16 U.S. patents for stem cells and drug discovery, and his research focuses on the relationship between stem cells, DNA and cancer. These discoveries have led to two agents in cancer clinical trials across the nation.
Under Gerson's leadership last year, the National Cancer Institute designated the Case CCC "exceptional," the highest rating possible. The Center, which serves the cancer research and clinical needs of more than four million people in Ohio and beyond, is one of only a handful of 50 such entities to earn an exceptional rating after extensive review of its programs.
"Stan's innovative research and ability to mentor up-and-coming cancer researchers makes him an ideal choice for the NAI Senior Member class," said Pamela B. Davis, MD, PhD, Dean the School of Medicine and Senior Vice President of Medical Affairs at Case Western Reserve University. "His patents will continue to drive us forward in providing new therapies for patients across Cleveland and throughout the world."